| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.00098 | 1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.00092 | 1 |